Aktienanalyse zu AirSculpt Technologies Inc (AIRS)AIRSAirSculpt Technologies Inc

AirSculpt Technologies, Inc. is engaged in providing body contouring treatment. The Company's treatment procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for healing with minimal bruising, tighter skin, and precise results. It offers a range of fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. It also offers AirSculpt +, which permanently removes fat and tightens the skin. Its treatment combines helium gas and radiofrequency energy to create a plasma equipped to correct sagging skin and restore a youthful, natural appearance. It operates in the Healthcare sector (SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE industry).

Airsculpt Technologies Inc is not a strong buy right now due to its current price of $1.20, which is significantly below its analyst price target of $5, indicating potential upside. However, the RSI of 16.316 suggests the stock is oversold, which could indicate a potential rebound. The main risk is its recent performance, with a 1-year change of -89.70%, indicating significant volatility and potential instability.